Identification of risk factors and development of a predictive model in patients using cefmetazole for international normalized ratio elevation.
Patient risk factors related to coagulopathy and bleeding when using cefmetazole (CMZ) have not yet been identified, and no models exist to predict side effects during CMZ treatment. Moreover, reports that examine which patients should be careful when using CMZ to ensure safety are lacking. Our obje...
Saved in:
| Main Authors: | Takaya Namiki, Yuta Yokoyama, Motonori Kimura, Shogo Fukuda, Shoji Seyama, Osamu Iketani, Masaru Samura, Haruki Ishikawa, Aya Jibiki, Hitoshi Kawazoe, Hisakazu Ohtani, Naoki Hasegawa, Kazuaki Matsumoto, Hideki Hashi, Sayo Suzuki, Tomonori Nakamura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322909 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of risk factors and development of a predictive model in patients using cefmetazole for international normalized ratio elevation
by: Takaya Namiki, et al.
Published: (2025-01-01) -
Reducing Infectious Complications and Healthcare Costs in Transrectal Ultrasound-Guided Prostate Biopsy with Single-Dose Cefmetazole and Levofloxacin
by: Katsuhiro Onishi, et al.
Published: (2024-12-01) -
Concurrent pseudogout and septic arthritis in native knee joint by ESBL-producing E. coli: Successful management with cefmetazole and surgery
by: Yoshihiro Aoki, et al.
Published: (2025-01-01) -
Cefmetazole, flomoxef, and meropenem are effective against planktonic cells but not biofilms of extended-spectrum β-lactamase-producing Escherichia coli
by: Nami Hatayama, et al.
Published: (2025-07-01) -
Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: combined retrospective analyses of two real-world databases and in vitro data
by: Takahiro Niimura, et al.
Published: (2025-07-01)